Vnitr Lek 2013, 59(8):747-751

Recent possibilities of treatment of End Stage Renal Desease

O. Viklický*, S. Rajnochová-Bloudíčková
Klinika nefrologie, Transplantační centrum IKEM Praha, přednosta prof. MUDr. Ondřej Viklický, CSc.

The End Stage Renal Deasease (ESRD) represents a significant medical and economic problem. The success of long-term outcome of ESRD is dependent on the adequate nephrological care. The treatment of choice represents a kidney transplantation from a living donor or in those who haven't got such possibility, a deceased donor kidney transplantation. Recently, number of living donor kidney transplants has been increasing during last years in Europe and USA, mainly because of large awareness campaign and by using incompatible pairs. There were 361 (34.3 pmp) deceased donor and 71 (6.7 pmp) living donor kidney transplants performed while 4,050 patients benefit the life with functioning kidney graft in the Czech Republic in 2012. Hemodialysis therapy had undergone 5,772 (550 pmp) while peritoneal dialysis 489 (47 pmp) patients on December 31st, 2012.

Keywords: ESRD; chronic kidney disease; dialysis; transplantation; peritoneal dialysis; CKD; Czech Republic

Received: April 6, 2013; Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Viklický O, Rajnochová-Bloudíčková S. Recent possibilities of treatment of End Stage Renal Desease. Vnitr Lek. 2013;59(8):747-751.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Meier-Kriesche HU, Schold JD. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial 2005; 18: 499-504. Go to original source... Go to PubMed...
    2. Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 1311-1317. Go to original source... Go to PubMed...
    3. Gill JS, Rose C, Pereira BJ et al. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 2007; 71: 442-447. Go to original source... Go to PubMed...
    4. Delmonico F. A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines. Transplantation 2005; 79 (Suppl 6): S53-S66. Go to original source... Go to PubMed...
    5. Genberg H, Kumlien G, Wennberg L et al. Isoagglutinin adsorption in ABO-incompatible transplantation. Transfus Apher Sci 2010; 43: 231-235. Go to original source... Go to PubMed...
    6. Segev DL, Simpkins CE, Warren DS et al. AB0 incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570-2575. Go to original source... Go to PubMed...
    7. Montgomery RA. Renal transplantation across HLA and AB0 antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 2010; 10: 449-457. Go to original source... Go to PubMed...
    8. Wadström J. Hand-assisted retroperitoneoscopic live donor nephrectomy: experience from first 75 consecutive cases. Transplantation 2005; 80: 1060-1066. Go to original source... Go to PubMed...
    9. Foley RN, Ibrahim HN. Long-term outcome of kidney donors. Curr Opin Nephrol Hypertens 2010; 19: 129-133. Go to original source... Go to PubMed...
    10. Danovitch GM, Hariharan S, Pirsch JD et al. Clinical Practice Guidelines Committee of the American Society of Transplantation. Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol 2002; 13: 528-535. Go to original source... Go to PubMed...
    11. Wauters JP, Lameire N, Davison A et al. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant 2005; 20: 490-496. Go to original source... Go to PubMed...
    12. Chow KM, Szeto CC, Law MC et al. Impact of early nephrology referral on mortality and hospitalization in peritoneal dialysis patients. Perit Dial Int 2008; 28: 371-376. Go to original source... Go to PubMed...
    13. KDIGO 2013. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Supplement 2013; 3: 19-62.
    14. Česká nefrologická společnost. Dostupné na: www.nefrol.cz.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.